IPP Bureau
Cantourage and Clever leaves intensify partnership for distribution of medical cannabis in Germany
By IPP Bureau - June 12, 2022
Cantourage introduces second Clever Leaves medical cannabis product to the German market
China NMPA approves Tislelizumab for metastatic nasopharyngeal cancer
By IPP Bureau - June 12, 2022
Tislelizumab is now approved in nine indications in China
Modi Inaugurates hospital complex and CoE in South Gujarat
By IPP Bureau - June 11, 2022
Centre of Excellence at Kharel comprises Skill-building Centre and Primary, Secondary and Higher Secondary schools
Eppendorf India inaugurates pipette laboratory and service hub in Chennai
By IPP Bureau - June 11, 2022
SPLASH also houses the tools’ calibration for epMotion, Eppendorf automated liquid handling workstations.
TaCa Healthcare expands its operations to Telangana and Andhra Pradesh
By IPP Bureau - June 11, 2022
Plans to establish six state of the art TaCa Centre for Surgery in next 2 years in these states
Takeda’s dengue vaccine candidate offers protection against dengue fever in clinical trial
By IPP Bureau - June 11, 2022
TAK-003 is currently undergoing regulatory review for potential licensure in both the European Union
Sanyou Biopharmaceuticals launches Super-Trillion Antibody Libraries
By IPP Bureau - June 11, 2022
New milestone in the establishment of super-trillion antibody libraries for antibody discovery of challenging targets
AIkido Pharma appoints Soo Yu as Director
By IPP Bureau - June 11, 2022
New Director supports NASDAQ rule on diversity
Illumina appoints Joydeep Goswami as Interim CFO
By IPP Bureau - June 11, 2022
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
AeroSafe Global appointment Jessica Cao as Sr VP (Marketing)
By IPP Bureau - June 11, 2022
Company hires life science veteran Jessica Cao to join management team
Nippon Express launches ultra-low temperature-controlled service for pharma industry
By IPP Bureau - June 11, 2022
Nippon Express has provided a pharmaceutical distribution platform with strict temperature control in two ranges -- 2 C to 8 C
Marinus expands enrollment criteria to support recruitment in Phase 3 RAISE Trial in refractory status epilepticus
By IPP Bureau - June 10, 2022
Marinus has broadened inclusion criteria in the RAISE trial to allow for enrollment of patients previously treated with IV anesthesia.
Olema Oncology and Aurigene collaboration to discover and develop novel cancer therapies
By IPP Bureau - June 10, 2022
During the research term, Olema will contribute funding to Aurigene to facilitate ongoing discovery efforts.
Sanofi launches its first Digital Accelerator fueled by new talent and focused on growth
By IPP Bureau - June 10, 2022
The Accelerator will develop products and solutions that will support Sanofi’s mission to transform the practice of medicine with the use of digital, data and artificial intelligence (AI).
Sanofi Dupixent gets USFDA nod for atopic dermatitis
By IPP Bureau - June 10, 2022
Dupixent is the first and only biologic medicine approved to treat moderate-to-severe atopic dermatitis from infancy to adulthood
